References

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

10.1056/nejmoa043330 · 2005 · External reference

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

10.1056/nejmoa1308345 · 2014 · External reference

A randomized trial of bevacizumab for newly diagnosed glioblastoma

10.1056/nejmoa1308573 · 2014 · External reference

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981–22981/CE.3

10.1016/s1470-2045(07)70384-4 · 2008 · External reference

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

10.1038/nrneurol.2009.197 · 2010 · External reference

Hallmarks of cancer: the next generation

10.1016/j.cell.2011.02.013 · 2011 · External reference

Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression

10.1007/s11060-014-1366-9 · 2014 · External reference

Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma

10.1186/s12885-015-1629-7 · 2015 · External reference

The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme

10.1007/s11060-013-1164-9 · 2013 · External reference

Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma

10.1038/bjc.2014.162 · 2014 · External reference

The split nature of tumor-infiltrating leukocytes

10.4161/onci.20068 · 2012 · External reference

Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis

10.1371/journal.pone.0098259 · 2014 · External reference

Leukocytosis and neutrophilia predicts outcome in anal cancer

10.1016/j.radonc.2016.12.009 · 2016 · External reference

Neutrophilia in locally advanced cervical cancer: a novel biomarker for image-guided adaptive brachytherapy?

10.18632/oncotarget.12440 · 2016 · External reference

Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients

10.1016/j.radonc.2016.01.001 · 2016 · External reference

Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients

10.1080/2162402x.2015.1075693 · 2016 · External reference

Neutrophil infiltration into human gliomas

10.1007/s004010051093 · 1999 · External reference

Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors

10.1056/nejmoa1407279 · 2015 · External reference

Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN

10.1016/j.ccr.2009.06.017 · 2009 · External reference

Tumor-associated neutrophils: friend or foe?

10.1093/carcin/bgs123 · 2012 · External reference

A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors

10.4103/0022-3859.180551 · 2016 · External reference

CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients

10.1093/neuonc/nov280 · 2016 · External reference

Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I

10.1158/1078-0432.ccr-11-1107 · 2011 · External reference

Corticosteroids compromise survival in glioblastoma

10.1093/brain/aww046 · 2016 · External reference

Neutrophils in cancer development and progression: roles, mechanisms, and implications (Review)

10.3892/ijo.2016.3616 · 2016 · External reference

TGF beta signaling and its role in glioma pathogenesis

2013 · External reference

Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF

10.1073/pnas.1613187113 · 2016 · External reference